Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

AI450540 Activators

The designation "AI450540" appears to represent a specific identifier within a chemical class, possibly denoting a group of compounds sharing common structural features or biological activities. The initial approach to understanding and categorizing a compound like AI450540 would involve a series of analytical techniques aimed at elucidating its chemical structure and attributes. First, chemists would employ nuclear magnetic resonance (NMR) spectroscopy, which can reveal the molecular skeleton by providing detailed information about the types of atoms present and their arrangement within the molecule. Complementary to NMR, mass spectrometry (MS) would be utilized to determine the compound's molecular mass and to deduce its empirical formula. Moreover, infrared (IR) spectroscopy could be applied to identify characteristic functional groups, while ultraviolet-visible (UV-Vis) spectroscopy could be used to explore electronic transitions within the molecule that may correlate with specific structural components. These collective data would afford a comprehensive understanding of the chemical identity of AI450540.

Once the primary structure of AI450540 is determined, the focus would shift to examining its chemical properties and behaviors. Analysts would assess the solubility of the compound in various solvents, which is essential for understanding its interactions and stability under different conditions. The reactivity of the compound would also be scrutinized, potentially using techniques such as chromatography to isolate and identify reaction products. Further, differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) can provide insights into the thermal properties of the compound, including its melting point and thermal decomposition profile. If AI450540 is designed to interact with biological systems, biochemical assays could be performed to elucidate its effects on isolated proteins, such as enzymes or receptors.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG is a tyrosine kinase inhibitor. By inhibiting competitive tyrosine kinase signaling, it may indirectly increase the activity of Protein BC062949 if it is regulated by tyrosine phosphorylation.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

S1P binds to its receptors, initiating signaling cascades that could lead to the activation of Protein BC062949 if it is involved in sphingolipid signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K, it could shift the balance of intracellular signaling to favor pathways that activate Protein BC062949, assuming it is part of the PI3K/AKT pathway.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is a PKC activator. Activation of PKC may lead to the enhancement of Protein BC062949 activity if it is a substrate of PKC or is regulated by PKC-mediated signaling.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially enhancing Protein BC062949 if it is part of calcium-dependent signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK could indirectly activate Protein BC062949 if it is upregulated as a result of p38 MAPK inhibition.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is an inhibitor of MEK1/2, potentially leading to the activation of Protein BC062949 if it is involved in the ERK/MAPK signaling pathway.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 acts as a mobile ion carrier for Ca²⁺, potentially enhancing the activity of Protein BC062949 through calcium-dependent pathways.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a SERCA pump inhibitor that increases cytosolic calcium levels, which could activate Protein BC062949 if it is involved in calcium signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is another PI3K inhibitor that could enhance Protein BC062949 activity by altering downstream AKT signaling, assuming the protein is part of this pathway.